Pharma IQ Members

Informatics

Find out which informatics are right for your lab. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in pharmaceutical, biotech and life science laboratories to exchange ideas on best practice and share case studies on laboratory innovation and automation within the area.

218 results
of 20
Contributor: Pharma IQ
Posted: 14/07/2017
Pharma IQ
Artificial intelligence could herald a new era for drug development but caution remains about how revolutionary its impact will actually be Full Content »
Contributor: Pharma IQ
Posted: 30/06/2017
Pharma IQ
Data hosted in digital lab systems is more vulnerable to corruption and authorized amends if not safeguarded by relevant procedures, password access and audit trails. This whitepaper examines the subject of security and data integrity in the lab. Full Content »
Contributor: Pharma IQ
Posted: 27/06/2017
Pharma IQ
Ahead of the 16th Laboratory Informatics Summit, Pharma IQ asked a set of experts to provide their insight into trends within the use of structured and unstructured data in the lab informatics world. Commentary is provided by Darryl Davies, Associate Director, Janssen. Full Content »
Posted: 10/03/2017
IDBS
This infographic explores the obstacles regularly faced by biopharmaceutical organizations, such as rising costs, repeated experiments, lack of searchability and quality assurance. Full Content »
Contributor: Social Monsters.org
Posted: 14/02/2017
default profile icon
After years of resistance, the health care and pharmaceutical industries are now accelerating full steam towards the cloud. In fact, the global health care cloud computing market, valued at $4.5 billion in 2016, will reach $9.5 billion by 2020. Here are the dominant benefits that are drawing these giants to the cloud. Full Content »
Contributor: Social Monsters.org
Posted: 10/01/2017
default profile icon
Health experts and medical personnel will be the first to say that the medical field is lagging behind when it comes to technology and innovation. Full Content »
Posted: 20/12/2016
Software design, medical devices, med devices, software for medical devices, medical software, apps
The Medical Device Technologies Market is forecasted to undergo exponential growth from 2015 up to 2021. Forecasted global market value for emerging medical device technologies by 2021: £90.8bn This is from 2016’s valuation of $55.9 billion Full Content »
Contributor: Pharma IQ
Posted: 20/12/2016
Pharma IQ
The last quarter of 2016 was certainly not short of activity with a £84 million pharma fine issued in regards to drug pricings, an investigation into a suspected supply chain breach and numerous therapeutic approvals. Full Content »
Contributor: Paul Denny-Gouldson
Posted: 01/11/2016
Paul Denny-Gouldson
The meeting was kicked off by John Wise, Executive Director at Pistoia Alliance, who shared a delightful, anecdote-filled review of the current pharma R&D business landscape. In his talk, he gave detailed evidence of how different pharma companies were comparing the amount they spend to bring each new drug to market. He highlighted just ‘being big’ was not enough, and explained how a company’s approach to innovation also plays a role in the drug discovery process. Full Content »
Contributor: Pharma IQ News
Posted: 18/10/2016
Pharma IQ News
Following a quarter that featured reports stating that Novartis had dramatically redistributed its cell and gene therapy unit 1 and saw the public focus turn once again to drug price hikes, Pharma IQ brings you the pharma, biotech and life sciences news highlights for Q3 of 2016. Full Content »
Contributor: Pharma IQ
Posted: 26/07/2016
Pharma IQ
Much growth in the sector is being driven by expansion into developing markets, thus increasing demand for people with international experience. Taking the supply chain as an example, although track-and-trace initiatives should simplify and facilitate logistics in the long-term, in the short term there may be increasing competition for those with specialist knowledge of developing markets. Full Content »
218 results
of 20